Monday, September 8, 2025, 7:00 PM Central Time / 8:00 PM Eastern Time
Join us for the SVM Vascular Medicine Journal Club, Monday, September 8, 2025, 7:00 PM CT / 8:00 PM ET
For this iteration of the SVM Journal Club, we will be joined by Dr. Marc Bonaca, as we review the STRIDE trial, a landmark study published in The Lancet:
Bonaca MP, Catarig AM, Houlind K, Ludvik B, Nordanstig J, Ramesh CK, Rasouli N, Sourij H, Videmark A, Verma S; STRIDE Trial Investigators. Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial. Lancet. 2025 May 3;405(10489):1580-1593.